Table 2.

Treatment-related adverse events occurring in ≥10% of patients

Adverse eventAny grade, N (%)Grade III–IV, N (%)
Thrombocytopenia24 (62)16 (41)
Diarrhea19 (49)2 (5)
Nausea18 (46)1 (3)
Fatigue14 (36)2 (5)
Decreased appetite7 (18)
AST elevation7 (18)3 (8)
Neutropenia6 (15)4 (10)
ALT elevation6 (15)3 (8)
Dehydration4 (10)2 (5.1)
Dyspepsia4 (10)
Dysgeusia4 (10)

NOTE: Adverse events possibly, probably, or definitely related are included.

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase.